Liquidity Agreement and Total Voting Rights
04/03/2019
RNS
Funding Update
26/02/2019
01/02/2019
Revenues Full Year 2018
22/01/2019
02/01/2019
Trading Update
24/12/2018
Novacyt launches two new molecular diagnostic kits
21/12/2018
Update on Strategic Review
11/12/2018
Completion of q16 molecular diagnostics order
06/12/2018
03/12/2018
Replacement: Unsecured Debt Facility
30/11/2018
$3.0M supply agreement with Genesis Diagnostics
27/11/2018
Liquidity Agreement
01/11/2018
01/10/2018
Novacyt Half Year 2018 Results
26/09/2018
Novacyt Partners with Applied Microarrays
13/09/2018
03/09/2018
02/08/2018
Half Year Revenue Update
Revenue update to be announced on 2 August 2018
26/07/2018
For Investor Relations Support for the Novacyt Group, please click the button below to contact our team.
